Principal, National Sector Leader for HCLS, KPMG US
Thriving in a converging environment: learn how KPMG can help pharmaceutical, medical device and diagnostic companies turn disruption into opportunity.
Analysis of the 2020 KPMG Healthcare and Life Sciences Investment Outlook survey sheds light on how the investment landscape will be impacted by influential disruptors, evolving market trends, and policy/regulatory developments.
Despite progress, companies are still facing many questions
Forward-thinking Life Sciences CXOs will transform Quality from a cost center to a value creator
Key insights and opportunities to unlock additional value by streamlining Regulatory Affairs operational activities
Despite progress in corporate cybersecurity, life sciences operational technology is still vulnerable to increasingly sophisticated threats.
Building a culture of excellence in healthcare
Instead of viewing calls for transparency as a burden, pharmaceutical companies can take steps to turn pricing reform to their advantage.
Proposed safe harbor changes open for comment
Consider applying for the voluntary initiative
Rising to the data challenge
2019 Health Care & Life Sciences Investment Outlook
Reinvent innovation and become an R&D front-runner by 2030
Unlocking value for life sciences organizations
This CIO Survey is the largest IT leadership study in the world, and summarizes what we learned about the transformational CIO.
KPMG/RAPS survey illustrates the ground medical device companies still have to cover
2018 Program benchmark report
Identifying opportunities for life sciences manufacturers.
Innovation in the life sciences finance function
As new entrants and cross-sector models abound, which direction should healthcare organizations turn?
Blockchain could be a key to interoperability and privacy
New standard. New challenges.
Healthcare and life sciences will face continued disruption in 2018 as new technologies, economic pressures and consumer/patient demands change the industry.
Navigating a transforming life sciences landscape
GDPR in Life Sciences Reference Card
A focused approach to winning in 2030
Register to receive timely insights
Meet our team